Nifedipine-induced coronary vasodilation in ischemic hearts is attributable to bradykinin- and NO-dependent mechanisms in dogs

Circulation

Volumn 101, Issue 3, 2000, Pages 311-317

  Kitakaze, Masafumi ^a   Asanuma, Hiroshi ^a   Takashima, Seiji ^a   Minamino, Tetsuo ^a   Ueda, Yasunori ^a   Sakata, Yasuhiko ^a   Asakura, Masanori ^a   Sanada, Shoji ^a   Kuzuya, Tsunehiko ^a   Hori, Masatsugu ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Blood flow; Bradykinin; Ischemia; Nitric oxide

Indexed keywords

BRADYKININ; CALCIUM CHANNEL BLOCKING AGENT; DIHYDROPYRIDINE DERIVATIVE; ICATIBANT; N(G) NITROARGININE METHYL ESTER; NIFEDIPINE; NITRIC OXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DILATATION; DOSE RESPONSE; DRUG MECHANISM; HEART CONTRACTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE METABOLISM; INTRACORONARY INFUSION; NONHUMAN; PRIORITY JOURNAL; TISSUE LEVEL; TREATMENT OUTCOME;

EID: 0034711685     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.101.3.311     Document Type: Article

References (22)

1. Opie LH. Should calcium antagonists be used after myocardial infarction? Ischemia selectivity versus vascular selectivity. Cardiovasc Drugs Ther. 1993;6:19-24.
2. 2+ antagonist-induced vasodilation: intracellular actions. Circ Res. 1983;52:137-142.
3. Bassenge E, Heusch G. Endothelial and neuro-humoral control of coronary blood flow in health and disease. Rev Physiol Biochem Pharmacol. 1990;116:77-165.
4. Fujimura Y, Tsuboi H, Esato K. Efficacy of benidipine hydrochloride on myocardial ischemia and reperfusion. J Surg Res. 1995;59: 321-325.
5. Zhang X, Hintze TH. Amlodipine releases nitric oxide from canine coronary microvessels: an unexpected mechanism of action of a calcium channel-blocking agent. Circulation. 1998;97:576-580.
6. Kitakaze M, Node K, Minamino T, Asanuma H, Kuzuya T, Hon M. A novel Ca channel blocker, benidipine, increases coronary blood flow and attenuates the seventy of myocardial ischemia via NO-dependent mechanisms in the dogs. J Am Coll Cardiol. 1999;33: 242-249.
7. Bergmeyer HU. Methods of Enzymatic Analysis. 1st ed. New York, NY: Academic Press Inc; 1963;266-270.
8. 15N]nitrate in biological fluids. Anal Biochem. 1982;126:131-138.
9. Mashford ML, Roberts ML. Determination of blood kinin levels by radioimmunoassay. Biochem Pharmacol. 1972;21:2727-2735.
10. Honma M, Satoh T, Takezawa J, Ui M. An ultrasensitive method for the simultaneous determination of cyclic AMP and cyclic GMP in small-volume samplings from blood and tissue. Biochem Med. 1977; 18:257-273.
11. Snedecor GW, Cochran WG. Statistical Methods. Ames, Iowa: Iowa State University Press; 1972:258-298.
12. Steel RGD, Torrie JH. Principles and Procedures of Statistics: A Biomedical Approach. 2nd ed. New York, NY: McGraw-Hill Publishing Co; 1980:137-238.
13. Ignarro LJ, Buga GM, Wood KS, Byrns RE, Chaudhuri G. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci U S A. 1987;84:9265-9269.
14. Kitakaze M, Node K, Komamura K, Minamino T, Inoue M, Hori M, Kamada T. Evidence for nitric oxide generation in the cardiomyocytes: its augmentation by hypoxia. J Mol Cell Cardiol. 1995;27: 2149-2154.
15. Chen LY, Mehta JL. Evidence for the presence of L-arginine-nitric oxide pathway in human red blood cells: relevance in the effects of red blood cells on platelet function. Cardiovasc Pharmacol. 1998;32:57-61.
16. Berkels R, Stockklauser K, Rosen P, Rosen R. Current status of platelet NO synthases. Thromb Res. 1997;87:51-55.
17. Amin AR, Attur M, Vyas P, Leszczynska-Piziak J, Levartovsky D, Rediske J, Clancy RM, Vora KA, Abramson SB. Expression of nitric oxide synthase in human peripheral blood mononuclear cells and neutrophils. J Inflamm. 1995-96;47:190-205.
18. Farivar RS, Chobanian AV, Brecher P. Salicylate or aspirin inhibits the induction of the inducible nitric oxide synthase in rat cardiac fibroblasts. Circ Res. 1996;78:759-768.
19. Yoshida K, Kohzuki M, Yasujima M, Kanazawa M, Abe K. Effects of benidipine, a calcium antagonist, on urinary kallikrein excretion and renal impairment in experimental diabetes. J Hypertens. 1996;14: 215-222.
20. Node K, Kitakaze M, Komamura K, Minamino T, Kosaka H, Inoue M, Tada M, Hori M, Kamada T. Endogenous nitric oxide reduces myocardial inotropic responses in ischemic myocardium of the canine heart. Circulation. 1996;93:356-364.
21. Zanzinger J, Czachurski J, Seller H. Neuronal nitric oxide reduces sympathetic excitability by modulation of central glutamate effects in pigs. Circ Res. 1997;80:565-571.
22. Qui Y, Tang XL, Manchikalapudi S, Takano H, Jadoon AK, Wu WJ, Bolli R. Nitric oxide triggers late preconditioning against myocardial infarction in conscious rabbits. Am J Physiol. 1997;273: H2931-H2936.